SEC Form 4 · accession 0001615774-15-001331
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Link Ph.D.
Director · 10% Owner
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 7:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 1, 2015 | A | 5,438 | $12.32 | A | 5,438 | D | |
| Common StockF3 | holding | — | — | — | 4,492,975 | I | . |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F15,438 shares awarded to William J. Link for serving on the Board of the Directors of the Company and its committees.
- F2Amount of shares awarded was calculated based on an average closing price of "EYES" stock for the preceding twenty trading days of our common stock on its principal exchange.
- F3As previously reported on Form 3 filed with the Commission on November 18, 2014 as amended, 4,370,964 shares are held by Versant Venture Capital II, L.P. ("VVC II"). Versant Ventures II, LLC ("VV II") serves as the sole general partner of VVC II, 82,949 shares are held by Versant Affiliates Fund II-A, L.P. ("VAF II-A"). VV II serves as the sole general partner of VAF II-A, 39,062 shares are held by Versant Side Fund II, L.P. ("VSF II"). VV II serves as the sole general partner of VSF II. The reporting person is a managing director and/or member of VV II and shares voting and dispositive power over the shares held by VVC II, VAF II-A and VSF II. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Remarks
# Pursuant to power of attorney.